Related Experiment Video

Updated: Aug 11, 2026

Comprehensive Autopsy Program for Individuals with Multiple Sclerosis
09:41

Comprehensive Autopsy Program for Individuals with Multiple Sclerosis

Published on: July 19, 2019

Myelin basic protein-like material in the urine of multiple sclerosis patients: relationships to clinical and

J N Whitaker1

  • 1Department of Neurology, University of Alabama at Birmingham, USA.

Multiple Sclerosis (Houndmills, Basingstoke, England)
|October 8, 1998
PubMed

Insights

Elevated urinary myelin basic protein-like material (MBPLM) indicates higher disease burden in secondary progressive multiple sclerosis (MS). This biomarker shows potential for personalized MS treatment monitoring.

Area of Science:

  • Neuroimmunology
  • Biomarker Discovery
  • Multiple Sclerosis Pathophysiology

Background:

  • Urinary myelin basic protein-like material (MBPLM) is cross-reactive with a human myelin basic protein epitope.
  • MBPLM levels are moderately present in adults but elevated in secondary progressive multiple sclerosis (SPMS).

Purpose of the Study:

  • To investigate the correlation between urinary MBPLM and disease burden in MS patients.
  • To identify the need for chemical characterization of MBPLM for assay improvement and understanding its biological role.
  • To explore the application of MBPLM data for personalized MS treatment and effectiveness monitoring.

Main Methods:

  • Measurement of urinary MBPLM levels.
  • Correlation analysis with T2-weighted cranial magnetic resonance imaging for disease burden assessment.
  • Distinguishing correlations in secondary progressive MS versus relapsing-remitting MS.

Main Results:

  • Increased urinary MBPLM correlates with greater disease burden in SPMS, as shown by MRI.
  • No correlation was found between urinary MBPLM and acute disease activity in relapsing-remitting MS.
  • Urinary MBPLM shows potential as a biomarker for disease progression in MS.

Conclusions:

  • Urinary MBPLM levels are associated with the cumulative disease burden in SPMS.
  • Further research is needed to define MBPLM's chemical nature and biological function.
  • Urinary MBPLM holds promise for guiding individualized MS treatment strategies and evaluating therapeutic efficacy.

More Related Videos

Positron Emission Tomography Imaging for In Vivo Measuring of Myelin Content in the Lysolecithin Rat Model of Multiple Sclerosis08:40

Positron Emission Tomography Imaging for In Vivo Measuring of Myelin Content in the Lysolecithin Rat Model of Multiple Sclerosis

Published on: February 28, 2021

Magnetic Resonance Imaging of Multiple Sclerosis at 7.0 Tesla08:51

Magnetic Resonance Imaging of Multiple Sclerosis at 7.0 Tesla

Published on: February 19, 2021

Related Concept Videos

Neural Regulation01:37

Neural Regulation

Digestion begins with a cephalic phase that prepares the digestive system to receive food. When our brain processes visual or olfactory information about food, it triggers impulses in the cranial nerves innervating the salivary glands and stomach to prepare for food.
Multiple Sclerosis l: Introduction01:19

Multiple Sclerosis l: Introduction

Multiple sclerosis is a chronic autoimmune disease of the central nervous system (CNS) that affects the brain, spinal cord, and optic nerves. It is an inflammatory demyelinating disorder and a leading cause of neurological disability in young adults.EpidemiologyMS commonly begins between 20 and 40 years of age and is twice as common in women. Its exact cause remains unclear, but genetic susceptibility contributes, with higher risk in first-degree relatives and identical twins. A greater...